Applied Pharmaceutical Analysis 2022 

 In-Person Event

September 19-21, Embassy Suites by Hilton Boston Waltham

 

Regulated Bioanalysis Workshop - Monday, September 19, 2022

Discovery Bioanalysis and New Technologies Workshop - Tuesday, September 20, 2022

Mechanistic ADME Workshop - Wednesday, September 21, 2022

Pat Walters

 PLENARY SPEAKER

 Pat Walters, PhD

Chief Data Officer @ Relay Therapeutics

Artificial Intelligence and In Silico ADMET Prediction

  Parag Mallick

 PLENARY SPEAKER

 Parag Mallick, PhD

Founder & Chief Scientist at Nautilus Biotechnology, Associate Professor @ Stanford University

The role of single-cell-omics in drug discovery - Talk Title TBA

Malaz Abutarif

 PLENARY SPEAKER

 Malaz Abutarif, PhD

Vice President of Quantitative Clinical Pharmacology @ Daiichi Sankyo

Talk Title TBA

steven j swanson APA2022

PLENARY SPEAKER

 Steven J Swanson, PhD, FAAPS

Senior Principal Scientist, Bioanalytical Sciences @ Genentech, Inc.

Talk Title TBA

 Eric Tewalt

  Eric Tewalt, PhD

Associate Director @ PPD, a part of Thermo Fisher Scientific

Strategies for Assessment of Oligonucleotide Biodistribution in Tissues via Hybridization ELISA

Jeffrey Kurz 

 Jeffrey Kurz, PhD

Associate Director @ Alnylam Pharmaceuticals

The ADME of C16 conjugates for CNS delivery - Title TBA

 
 Stephen Fowler APA2022

  Stephen Fowler, PhD

Clinical Pharmacologist @ F. Hoffmann La-Roche Ltd

Title TBA

 Andy Pike

Andy Pike, PhD

Senior DMPK Lead @ AstraZeneca 

Optimising Proteolysis Targeting Chimeras (PROTAC's) for Oral Drug Delivery: A drug metabolism and pharmacokinetics perspective

Heather Myler APA2019 

  Heather Myler, PhD

Executive Director Scientific Affairs, Analytical Sciences Division @ PPD

Supply Chain Impact on Drug Development: A Pandemic-driven Global Perspective

 Christine Callahan APA2022

Christine Callahan, MS

Vice President Supply Chain, Life Sciences Solutions @ Thermo Fisher Scientific

Enhancement of Capacity and Supply Chain Capabilities - Title TBA

 Pallavi Lonkar APA2022

  Pallavi Lonkar, PhD

Senior Director, Head of Bioanalytical, DMPK and Biomarkers @ PepGen

 The Promise of Peptide-Oligonucleotide Conjugates for Neuromuscular Diseases

 

Shelia Breidinger, PhD

Director, Regulated Bioanalytical Outsourcing, Merck & Co, Inc.

Bioanalysis of Molnupiravir - Title TBA

 

Yueting Wang

Yue-Ting Wang, PhD

Principal Reserarch Scientist, DMPK-BA @ AbbVie

To Infinity and Beyond Rule of Five Compounds: Challenges & Considerations for Discovery Stage Bioanalytical Support

 

Weixun Wang APA2022 

 

Weixun Wang, PhD

Group Leader Discovery Bioanalysis, Merck & Co, Inc.

Development of a Target Engagement (TE) Assay for the Oral Peptide PCSK9-LDLr Inhibitor Program

Jacques Saarbach

Jacques Saarbach, PhD

Post-doctoral Fellow, Crews Lab, MCDB, Yale University

PROTACs recent developments - Title TBA

Nanda B APA2022   

Nanda Balasubramanian, PhD

Senior Principal Scientist, Nonclinical Disposition and Bioanalysis, Bristol Myers Squibb

Bioanalytical Strategies and Challenges for CAR-T Support

Tong Yuan  

Tong-Yuan Yang, PhD

Senior Scientific Dierctor @ Janssen R&D; Adjunct Professor @ Department of Pharmacology, College of Medicine, Pennsiylvania State University

Title TBA

Tomo Kiyota 

Tomomi Kiyota, PhD

Principal Scientist @ Genentech

Renal Proximal Tubule-on-a-Chip: Performance, Utility, and Benefits for Toxicity Mitigation During Drug Development

Jason DelCarpini

Jason DelCarpini, PhD

Associate Dierctor, Quantitative Bioanalytics @ Moderna

NAB Assay Strategies - Title TBA

Michele Gunsior 

 

Michele Gunsior, PhD

Senior Director @ Astria Therapeutics

Harmonization of ADA Data Reporting - Title TBA

  Aaron Cooper, PhD

Senior Director of Synthetic Biology @ Arsenal Bio

 Title TBA

Haihong Shi, PhD

Director @ Pfizer

Title TBA

 

 Donglu Zhang, PhD

Staff Scientist @Genentech

The Importance of Tracking 'Missing' Metabolites - How and Why?

 

 Hisao Shimizu, PhD

Principal Scientist DMPK @ Takeda Pharmaceutical Company

Title TBA - Bioanalytical Approach for Diverse Oligonucleotides Therapeutics Using Multiple BA Platforms

APA 2022 Sessions

Regulated Bioanalysis Workshop

Session I: The State of the FDA - Guidance, Approval, and Beyond

Session II: Roadmap to the Approval of COVID-19 Treatments and Testing

Session III: Immunogenicity

Session IV: Emerging Technologies for New Modalities & Biomarkers

 

Discovery Bioanalysis and New Technologies Workshop

Session I: Advancements in AAV, mRNA, and Lipid Nanoparticle Technology for Viral and Gene Therapies

Session II: Bioanalysis of Oligonucleotide Therapeutics

Session III: Beyond the Rule of Five: Considerations in Bioanalysis and Data Analysis

 

Mechanistic ADME Workshop

Workshop Theme: Unmasking Unmet Need in the ADMET Space

Session I: Microphysiological Systems: Recent Advances in 3D Cell Culture Models & Beyond to Address Unmet Needs in ADMET

Session II: On the Battlefield with Analytical Challenges

Session III: Mechanistic ADME of Novel Modalities

 

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2022 conference.

APA 2022 will take place September 19-21, 2022

Embassy Suites by Hilton Boston Waltham

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy